Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author Correction: Regulation of urea cycle by reversible high-stoichiometry lysine succinylation.

Nature metabolism·2026

Same author

Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons.

Aging cell·2026

Same author

Ketone ester supplementation in aged mice reduces activation of B cell subsets.

bioRxiv : the preprint server for biology·2026

Same author

Replacement-Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions.

Aging cell·2026

Same author

p21<sup>+</sup>TREM2<sup>+</sup> senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.

Nature aging·2026

Same author

Toward actionable interventions in human aging (12th ARDD meeting, 2025).

Aging·2026

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

HAT trick: p300, small molecule, inhibitor.

Melanie Ott¹, Eric Verdin

¹Gladstone Institute of Virology and Immunology, Department of Medicine, University of California, San Francisco, 1650 Owens St., San Francisco, CA 94158, USA. mott@gladstone.ucsf.edu

Chemistry & Biology

|June 11, 2010

Summary

This summary is machine-generated.

Researchers identified small molecule inhibitors for p300, an enzyme involved in protein acetylation. This discovery holds potential for developing new therapeutic applications targeting acetylation processes.

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Related Experiment Videos

Last Updated: Jun 12, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Area of Science:

Biochemistry
Molecular Biology
Drug Discovery

Background:

p300 is a critical acetyltransferase regulating gene expression through lysine acetylation of histone and nonhistone proteins.
Aberrant p300 activity is implicated in various diseases, making it a significant therapeutic target.

Discussion:

Bowers et al. (2010) utilized structural information of p300 to perform an in silico screen for active site inhibitors.
This computational approach identified potential small molecules capable of modulating p300 enzymatic activity.

Key Insights:

The study presents a structure-based in silico screening strategy for identifying p300 inhibitors.
Discovery of novel small molecules targeting the p300 active site.

Outlook:

These identified inhibitors offer a promising starting point for the development of p300-targeted therapeutics.
Further research may explore the efficacy and safety of these compounds in preclinical and clinical settings.